118 related articles for article (PubMed ID: 38290634)
1. Modulation of macrophage polarity with carboxymethyl chitin gated hollow mesoporous silica nanoparticles for elevating anti-tumor chemotherapy.
Ding X; Liu X; Qiu T; Zhou Y; Michał N; Roman S; Liu Q; Liu Y; Peng N
Int J Biol Macromol; 2024 Mar; 261(Pt 2):129761. PubMed ID: 38290634
[TBL] [Abstract][Full Text] [Related]
2. A pH/ROS-responsive, tumor-targeted drug delivery system based on carboxymethyl chitin gated hollow mesoporous silica nanoparticles for anti-tumor chemotherapy.
Ding X; Yu W; Wan Y; Yang M; Hua C; Peng N; Liu Y
Carbohydr Polym; 2020 Oct; 245():116493. PubMed ID: 32718608
[TBL] [Abstract][Full Text] [Related]
3. Multi-functional carboxymethyl chitin-based nanoparticles for modulation of tumor-associated macrophage polarity.
Wan Y; Yu W; Li J; Peng N; Ding X; Wang Y; Zou T; Cheng Y; Liu Y
Carbohydr Polym; 2021 Sep; 267():118245. PubMed ID: 34119189
[TBL] [Abstract][Full Text] [Related]
4. Hollow Mesoporous Silica Nanoparticles Gated by Chitosan-Copper Sulfide Composites as Theranostic Agents for the Treatment of Breast Cancer.
Niu S; Zhang X; Williams GR; Wu J; Gao F; Fu Z; Chen X; Lu S; Zhu LM
Acta Biomater; 2021 May; 126():408-420. PubMed ID: 33731303
[TBL] [Abstract][Full Text] [Related]
5. A positive feedback strategy for enhanced chemotherapy based on ROS-triggered self-accelerating drug release nanosystem.
Hu JJ; Lei Q; Peng MY; Zheng DW; Chen YX; Zhang XZ
Biomaterials; 2017 Jun; 128():136-146. PubMed ID: 28325685
[TBL] [Abstract][Full Text] [Related]
6. Albumin-MnO
Fang J; Wang Q; Yang G; Xiao X; Li L; Yu T
Colloids Surf B Biointerfaces; 2019 Jul; 179():250-259. PubMed ID: 30978612
[TBL] [Abstract][Full Text] [Related]
7. Fabricating polydopamine-coated MoSe
Chai S; Kan S; Sun R; Zhou R; Sun Y; Chen W; Yu B
Int J Nanomedicine; 2018; 13():7607-7621. PubMed ID: 30510420
[TBL] [Abstract][Full Text] [Related]
8. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance.
Shao M; Chang C; Liu Z; Chen K; Zhou Y; Zheng G; Huang Z; Xu H; Xu P; Lu B
Colloids Surf B Biointerfaces; 2019 Nov; 183():110427. PubMed ID: 31408782
[TBL] [Abstract][Full Text] [Related]
9. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
[TBL] [Abstract][Full Text] [Related]
10. Polymeric Prodrug Grafted Hollow Mesoporous Silica Nanoparticles Encapsulating Near-Infrared Absorbing Dye for Potent Combined Photothermal-Chemotherapy.
Zhang Y; Ang CY; Li M; Tan SY; Qu Q; Zhao Y
ACS Appl Mater Interfaces; 2016 Mar; 8(11):6869-79. PubMed ID: 26937591
[TBL] [Abstract][Full Text] [Related]
11. Endogenous NO-release multi-responsive hollow mesoporous silica nanoparticles for drug encapsulation and delivery.
Wu S; Shi J; Chen X; Bai L; Wu Q; Zhang G
Colloids Surf B Biointerfaces; 2023 Jul; 227():113346. PubMed ID: 37230051
[TBL] [Abstract][Full Text] [Related]
12. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
[No Abstract] [Full Text] [Related]
13. TPGS functionalized mesoporous silica nanoparticles for anticancer drug delivery to overcome multidrug resistance.
Zhao P; Li L; Zhou S; Qiu L; Qian Z; Liu X; Cao X; Zhang H
Mater Sci Eng C Mater Biol Appl; 2018 Mar; 84():108-117. PubMed ID: 29519418
[TBL] [Abstract][Full Text] [Related]
14. A pH-sensitive prodrug strategy to co-deliver DOX and TOS in TPGS nanomicelles for tumor therapy.
Xiong S; Wang Z; Liu J; Deng X; Xiong R; Cao X; Xie Z; Lei X; Chen Y; Tang G
Colloids Surf B Biointerfaces; 2019 Jan; 173():346-355. PubMed ID: 30316081
[TBL] [Abstract][Full Text] [Related]
15. Hollow mesoporous silica nanoparticles facilitated drug delivery via cascade pH stimuli in tumor microenvironment for tumor therapy.
Liu J; Luo Z; Zhang J; Luo T; Zhou J; Zhao X; Cai K
Biomaterials; 2016 Mar; 83():51-65. PubMed ID: 26773665
[TBL] [Abstract][Full Text] [Related]
16. A surface-grafted ligand functionalization strategy for coordinate binding of doxorubicin at surface of PEGylated mesoporous silica nanoparticles: Toward pH-responsive drug delivery.
Zhang Q; Zhao H; Li D; Liu L; Du S
Colloids Surf B Biointerfaces; 2017 Jan; 149():138-145. PubMed ID: 27750088
[TBL] [Abstract][Full Text] [Related]
17. pH/H
Wang Y; Wang J; Gou K; Kang W; Guo X; Zhu K; Li S; Li H
ACS Appl Mater Interfaces; 2021 Aug; 13(30):35397-35409. PubMed ID: 34313104
[TBL] [Abstract][Full Text] [Related]
18. Construction and performance evaluation of pH-responsive oxidized hyaluronic acid hollow mesoporous silica nanoparticles.
Enyu X; Xinbo L; Xuelian C; Huimin C; Yin C; Yan C
Int J Biol Macromol; 2024 Feb; 257(Pt 1):128656. PubMed ID: 38065461
[TBL] [Abstract][Full Text] [Related]
19. Self-assembling doxorubicin-tocopherol succinate prodrug as a new drug delivery system: synthesis, characterization, and in vitro and in vivo anticancer activity.
Duhem N; Danhier F; Pourcelle V; Schumers JM; Bertrand O; Leduff CS; Hoeppener S; Schubert US; Gohy JF; Marchand-Brynaert J; Préat V
Bioconjug Chem; 2014 Jan; 25(1):72-81. PubMed ID: 24328289
[TBL] [Abstract][Full Text] [Related]
20. Glutathione-sensitive hollow mesoporous silica nanoparticles for controlled drug delivery.
Hadipour Moghaddam SP; Yazdimamaghani M; Ghandehari H
J Control Release; 2018 Jul; 282():62-75. PubMed ID: 29679666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
